0001181431-13-015382.txt : 20130307 0001181431-13-015382.hdr.sgml : 20130307 20130307165131 ACCESSION NUMBER: 0001181431-13-015382 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130305 FILED AS OF DATE: 20130307 DATE AS OF CHANGE: 20130307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gionco David CENTRAL INDEX KEY: 0001456864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13674016 MAIL ADDRESS: STREET 1: 9 HOWELL DRIVE CITY: FAR HILLS STATE: NJ ZIP: 07931 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd373245.xml GIONCO FORM 4 X0306 4 2013-03-05 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001456864 Gionco David SAVIENT PHARMACEUTICALS, INC. 400 CROSSING BLVD 3RD FLOOR BRIDGEWATER NJ 08807 0 1 0 0 Group VP & Chief Acct. Officer Common Stock 2013-03-05 4 A 0 29000 0.00 A 85200 D These shares of restricted stock will vest in proportional 1/3 increments on each of the first three anniversaries of the grant date, March 5, 2013. Philip K. Yachmetz as attorney-in-fact for David Gionco 2013-03-07